The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Low Molecular Weight Heparin Sodium Market Research Report 2025
Synopsis
This report mainly studies low molecular weight heparin sodium market. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention of blood clots and treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism) and in the treatment of myocardial infarction.
The global Low Molecular Weight Heparin Sodium market was valued at US$ 3896 million in 2023 and is anticipated to reach US$ 6020.7 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030.
Factors such as increasing advantages of low molecular weight heparin overunfractionated heparin and increasing introduction of biosimilar low molecularweight heparin anticoagulants globally are expected to drive the market growth.
This report aims to provide a comprehensive presentation of the global market for Low Molecular Weight Heparin Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Low Molecular Weight Heparin Sodium.
Report Scope
The Low Molecular Weight Heparin Sodium market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Low Molecular Weight Heparin Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Low Molecular Weight Heparin Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutica
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
Segment by Type
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine
Segment by Application
Medical
Research
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Low Molecular Weight Heparin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Low Molecular Weight Heparin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report mainly studies low molecular weight heparin sodium market. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention of blood clots and treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism) and in the treatment of myocardial infarction.
The global Low Molecular Weight Heparin Sodium market was valued at US$ 3896 million in 2023 and is anticipated to reach US$ 6020.7 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030.
Factors such as increasing advantages of low molecular weight heparin overunfractionated heparin and increasing introduction of biosimilar low molecularweight heparin anticoagulants globally are expected to drive the market growth.
This report aims to provide a comprehensive presentation of the global market for Low Molecular Weight Heparin Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Low Molecular Weight Heparin Sodium.
Report Scope
The Low Molecular Weight Heparin Sodium market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Low Molecular Weight Heparin Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Low Molecular Weight Heparin Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutica
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
Segment by Type
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine
Segment by Application
Medical
Research
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Low Molecular Weight Heparin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Low Molecular Weight Heparin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Low Molecular Weight Heparin Sodium Market Overview
1.1 Product Overview and Scope of Low Molecular Weight Heparin Sodium
1.2 Low Molecular Weight Heparin Sodium Segment by Type
1.2.1 Global Low Molecular Weight Heparin Sodium Market Value Comparison by Type (2024-2030)
1.2.2 Enoxaparin
1.2.3 Dalteparin
1.2.4 Tinzaparin
1.2.5 Fraxiparine
1.3 Low Molecular Weight Heparin Sodium Segment by Application
1.3.1 Global Low Molecular Weight Heparin Sodium Market Value by Application: (2024-2030)
1.3.2 Medical
1.3.3 Research
1.4 Global Low Molecular Weight Heparin Sodium Market Size Estimates and Forecasts
1.4.1 Global Low Molecular Weight Heparin Sodium Revenue 2019-2030
1.4.2 Global Low Molecular Weight Heparin Sodium Sales 2019-2030
1.4.3 Global Low Molecular Weight Heparin Sodium Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Low Molecular Weight Heparin Sodium Market Competition by Manufacturers
2.1 Global Low Molecular Weight Heparin Sodium Sales Market Share by Manufacturers (2019-2024)
2.2 Global Low Molecular Weight Heparin Sodium Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Low Molecular Weight Heparin Sodium Average Price by Manufacturers (2019-2024)
2.4 Global Low Molecular Weight Heparin Sodium Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Low Molecular Weight Heparin Sodium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Low Molecular Weight Heparin Sodium, Product Type & Application
2.7 Low Molecular Weight Heparin Sodium Market Competitive Situation and Trends
2.7.1 Low Molecular Weight Heparin Sodium Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Low Molecular Weight Heparin Sodium Players Market Share by Revenue
2.7.3 Global Low Molecular Weight Heparin Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Low Molecular Weight Heparin Sodium Retrospective Market Scenario by Region
3.1 Global Low Molecular Weight Heparin Sodium Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Low Molecular Weight Heparin Sodium Global Low Molecular Weight Heparin Sodium Sales by Region: 2019-2030
3.2.1 Global Low Molecular Weight Heparin Sodium Sales by Region: 2019-2024
3.2.2 Global Low Molecular Weight Heparin Sodium Sales by Region: 2025-2030
3.3 Global Low Molecular Weight Heparin Sodium Global Low Molecular Weight Heparin Sodium Revenue by Region: 2019-2030
3.3.1 Global Low Molecular Weight Heparin Sodium Revenue by Region: 2019-2024
3.3.2 Global Low Molecular Weight Heparin Sodium Revenue by Region: 2025-2030
3.4 North America Low Molecular Weight Heparin Sodium Market Facts & Figures by Country
3.4.1 North America Low Molecular Weight Heparin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Low Molecular Weight Heparin Sodium Sales by Country (2019-2030)
3.4.3 North America Low Molecular Weight Heparin Sodium Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Low Molecular Weight Heparin Sodium Market Facts & Figures by Country
3.5.1 Europe Low Molecular Weight Heparin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Low Molecular Weight Heparin Sodium Sales by Country (2019-2030)
3.5.3 Europe Low Molecular Weight Heparin Sodium Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Low Molecular Weight Heparin Sodium Market Facts & Figures by Country
3.6.1 Asia Pacific Low Molecular Weight Heparin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Low Molecular Weight Heparin Sodium Sales by Country (2019-2030)
3.6.3 Asia Pacific Low Molecular Weight Heparin Sodium Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Low Molecular Weight Heparin Sodium Market Facts & Figures by Country
3.7.1 Latin America Low Molecular Weight Heparin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Low Molecular Weight Heparin Sodium Sales by Country (2019-2030)
3.7.3 Latin America Low Molecular Weight Heparin Sodium Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Low Molecular Weight Heparin Sodium Market Facts & Figures by Country
3.8.1 Middle East and Africa Low Molecular Weight Heparin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Country (2019-2030)
3.8.3 Middle East and Africa Low Molecular Weight Heparin Sodium Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Low Molecular Weight Heparin Sodium Sales by Type (2019-2030)
4.1.1 Global Low Molecular Weight Heparin Sodium Sales by Type (2019-2024)
4.1.2 Global Low Molecular Weight Heparin Sodium Sales by Type (2025-2030)
4.1.3 Global Low Molecular Weight Heparin Sodium Sales Market Share by Type (2019-2030)
4.2 Global Low Molecular Weight Heparin Sodium Revenue by Type (2019-2030)
4.2.1 Global Low Molecular Weight Heparin Sodium Revenue by Type (2019-2024)
4.2.2 Global Low Molecular Weight Heparin Sodium Revenue by Type (2025-2030)
4.2.3 Global Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2019-2030)
4.3 Global Low Molecular Weight Heparin Sodium Price by Type (2019-2030)
5 Segment by Application
5.1 Global Low Molecular Weight Heparin Sodium Sales by Application (2019-2030)
5.1.1 Global Low Molecular Weight Heparin Sodium Sales by Application (2019-2024)
5.1.2 Global Low Molecular Weight Heparin Sodium Sales by Application (2025-2030)
5.1.3 Global Low Molecular Weight Heparin Sodium Sales Market Share by Application (2019-2030)
5.2 Global Low Molecular Weight Heparin Sodium Revenue by Application (2019-2030)
5.2.1 Global Low Molecular Weight Heparin Sodium Revenue by Application (2019-2024)
5.2.2 Global Low Molecular Weight Heparin Sodium Revenue by Application (2025-2030)
5.2.3 Global Low Molecular Weight Heparin Sodium Revenue Market Share by Application (2019-2030)
5.3 Global Low Molecular Weight Heparin Sodium Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Aspen
6.1.1 Aspen Corporation Information
6.1.2 Aspen Description and Business Overview
6.1.3 Aspen Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Aspen Low Molecular Weight Heparin Sodium Product Portfolio
6.1.5 Aspen Recent Developments/Updates
6.2 Sanofi-aventis
6.2.1 Sanofi-aventis Corporation Information
6.2.2 Sanofi-aventis Description and Business Overview
6.2.3 Sanofi-aventis Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi-aventis Low Molecular Weight Heparin Sodium Product Portfolio
6.2.5 Sanofi-aventis Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Low Molecular Weight Heparin Sodium Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Opocrin
6.4.1 Opocrin Corporation Information
6.4.2 Opocrin Description and Business Overview
6.4.3 Opocrin Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Opocrin Low Molecular Weight Heparin Sodium Product Portfolio
6.4.5 Opocrin Recent Developments/Updates
6.5 CSBIO
6.5.1 CSBIO Corporation Information
6.5.2 CSBIO Description and Business Overview
6.5.3 CSBIO Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CSBIO Low Molecular Weight Heparin Sodium Product Portfolio
6.5.5 CSBIO Recent Developments/Updates
6.6 Dongying Tiandong Pharmaceutica
6.6.1 Dongying Tiandong Pharmaceutica Corporation Information
6.6.2 Dongying Tiandong Pharmaceutica Description and Business Overview
6.6.3 Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Product Portfolio
6.6.5 Dongying Tiandong Pharmaceutica Recent Developments/Updates
6.7 Changzhou Qianhong Bio-pharma
6.6.1 Changzhou Qianhong Bio-pharma Corporation Information
6.6.2 Changzhou Qianhong Bio-pharma Description and Business Overview
6.6.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Product Portfolio
6.7.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
6.8 Techdow
6.8.1 Techdow Corporation Information
6.8.2 Techdow Description and Business Overview
6.8.3 Techdow Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Techdow Low Molecular Weight Heparin Sodium Product Portfolio
6.8.5 Techdow Recent Developments/Updates
6.9 Yantai Dongcheng Pharmaceutical Group
6.9.1 Yantai Dongcheng Pharmaceutical Group Corporation Information
6.9.2 Yantai Dongcheng Pharmaceutical Group Description and Business Overview
6.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Product Portfolio
6.9.5 Yantai Dongcheng Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Low Molecular Weight Heparin Sodium Industry Chain Analysis
7.2 Low Molecular Weight Heparin Sodium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Low Molecular Weight Heparin Sodium Production Mode & Process
7.4 Low Molecular Weight Heparin Sodium Sales and Marketing
7.4.1 Low Molecular Weight Heparin Sodium Sales Channels
7.4.2 Low Molecular Weight Heparin Sodium Distributors
7.5 Low Molecular Weight Heparin Sodium Customers
8 Low Molecular Weight Heparin Sodium Market Dynamics
8.1 Low Molecular Weight Heparin Sodium Industry Trends
8.2 Low Molecular Weight Heparin Sodium Market Drivers
8.3 Low Molecular Weight Heparin Sodium Market Challenges
8.4 Low Molecular Weight Heparin Sodium Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
